Effects of engineered nanoparticles on the innate immune system.

Engineered nanoparticles (NPs) have broad applications in industry and nanomedicine. When NPs enter the body, interactions with the immune system are unavoidable. The innate immune system, a non-specific first line of defense against potential threats to the host, immediately interacts with introduced NPs and generates complicated immune responses. Depending on their physicochemical properties, NPs can interact with cells and proteins to stimulate or suppress the innate immune response, and similarly activate or avoid the complement system. NPs size, shape, hydrophobicity and surface modification are the main factors that influence the interactions between NPs and the innate immune system. In this review, we will focus on recent reports about the relationship between the physicochemical properties of NPs and their innate immune response, and their applications in immunotherapy.

[1]  Liangzhu Feng,et al.  Antigen-Loaded Upconversion Nanoparticles for Dendritic Cell Stimulation, Tracking, and Vaccination in Dendritic Cell-Based Immunotherapy. , 2015, ACS nano.

[2]  Peter A. Ward,et al.  The complement system , 2010, Cell and Tissue Research.

[3]  P. Shi,et al.  Crystal Structure of the Dengue Virus Methyltransferase Bound to a 5′-Capped Octameric RNA , 2010, PloS one.

[4]  Majid Montazer,et al.  A review on the application of inorganic nano-structured materials in the modification of textiles: focus on anti-microbial properties. , 2010, Colloids and surfaces. B, Biointerfaces.

[5]  Jiwei Cui,et al.  Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery. , 2017, ACS nano.

[6]  W. Mark Saltzman,et al.  A holistic approach to targeting disease with polymeric nanoparticles , 2015, Nature Reviews Drug Discovery.

[7]  Andrew Emili,et al.  Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. , 2012, Journal of the American Chemical Society.

[8]  Arno C Gutleb,et al.  Influence of Size and Shape on the Anatomical Distribution of Endotoxin-Free Gold Nanoparticles. , 2017, ACS nano.

[9]  Li Tang,et al.  Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[10]  E. Lavik,et al.  Materials design at the interface of nanoparticles and innate immunity. , 2016, Journal of materials chemistry. B.

[11]  Meiying Wang,et al.  Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles. , 2013, ACS nano.

[12]  S. Al‐Muhsen,et al.  A novel anti-IL4Rα nanoparticle efficiently controls lung inflammation during asthma , 2016, Experimental & Molecular Medicine.

[13]  Moonjung Choi,et al.  Cellular uptake, cytotoxicity, and innate immune response of silica-titania hollow nanoparticles based on size and surface functionality. , 2010, ACS nano.

[14]  H. Kruth,et al.  Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions. , 2009, The Journal of clinical investigation.

[15]  S. Broderick,et al.  Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants. , 2011, Biomaterials.

[16]  A. Mohsenifar,et al.  Collagen-chitosan 3-D nano-scaffolds effects on macrophage phagocytosis and pro-inflammatory cytokine release , 2016, Journal of immunotoxicology.

[17]  Ronnie H. Fang,et al.  Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy. , 2015, Small.

[18]  Keishiro Tomoda,et al.  Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.

[19]  D. Drobne,et al.  Nanoparticle interaction with the immune system / Interakcije nanodelcev z imunskim sistemom , 2015, Arhiv za higijenu rada i toksikologiju.

[20]  J. Irache,et al.  Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators. , 2011, Vaccine.

[21]  Rujing Zhang,et al.  Suppression of Hepatic Inflammation via Systemic siRNA Delivery by Membrane-Disruptive and Endosomolytic Helical Polypeptide Hybrid Nanoparticles. , 2016, ACS nano.

[22]  Sudipta Seal,et al.  Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct. , 2009, ACS nano.

[23]  Yaolin Xu,et al.  The responses of immune cells to iron oxide nanoparticles , 2016, Journal of applied toxicology : JAT.

[24]  Jian Qin,et al.  The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. , 2006, Nano letters.

[25]  Dan Peer,et al.  Nanoparticle hydrophobicity dictates immune response. , 2012, Journal of the American Chemical Society.

[26]  B. Baradaran,et al.  Overview on experimental models of interactions between nanoparticles and the immune system. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[27]  Junjie Xu,et al.  Surface hydrophobicity of microparticles modulates adjuvanticity. , 2013, Journal of materials chemistry. B.

[28]  N. Gu,et al.  The internalization pathway, metabolic fate and biological effect of superparamagnetic iron oxide nanoparticles in the macrophage-like RAW264.7 cell , 2011, Science China Life Sciences.

[29]  Masakazu Umezawa,et al.  Effect of maternal exposure to carbon black nanoparticle during early gestation on the splenic phenotype of neonatal mouse. , 2014, The Journal of toxicological sciences.

[30]  Karolina Palucka,et al.  Cancer immunotherapy via dendritic cells , 2012, Nature Reviews Cancer.

[31]  Andrew Emili,et al.  Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. , 2014, ACS nano.

[32]  A. Haddadi,et al.  Delivery of rapamycin-loaded nanoparticle down regulates ICAM-1 expression and maintains an immunosuppressive profile in human CD34+ progenitor-derived dendritic cells. , 2008, Journal of biomedical materials research. Part A.

[33]  L. Moretta,et al.  KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing , 2017, Front. Immunol..

[34]  L. Zitvogel,et al.  Dendritic Cell–Derived Exosomes as Immunotherapies in the Fight against Cancer , 2014, The Journal of Immunology.

[35]  R. Steinhardt,et al.  Surface Coating of Nanoparticles Reduces Background Inflammatory Activity while Increasing Particle Uptake and Delivery. , 2017, ACS biomaterials science & engineering.

[36]  M. Kim,et al.  The use of anti-COX2 siRNA coated onto PLGA nanoparticles loading dexamethasone in the treatment of rheumatoid arthritis. , 2012, Biomaterials.

[37]  Ji-Ho Park,et al.  Endocytosis and exocytosis of nanoparticles in mammalian cells , 2014, International journal of nanomedicine.

[38]  L. Salassa,et al.  An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects , 2015, Advanced healthcare materials.

[39]  E. Fröhlich Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo , 2015, International journal of nanomedicine.

[40]  Jürgen Groll,et al.  Rapid uptake of gold nanorods by primary human blood phagocytes and immunomodulatory effects of surface chemistry. , 2010, ACS nano.

[41]  B. Malissen,et al.  Innate and adaptive immunity: specificities and signaling hierarchies revisited , 2004, Nature Immunology.

[42]  Daniel G. Anderson,et al.  Therapeutic siRNA silencing in inflammatory monocytes , 2011, Nature Biotechnology.

[43]  Anne L. van de Ven,et al.  Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.

[44]  Seyed Moein Moghimi,et al.  Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo. , 2017, Nature nanotechnology.

[45]  Yves-Jacques Schneider,et al.  Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[46]  Marina A Dobrovolskaia,et al.  Current understanding of interactions between nanoparticles and the immune system. , 2016, Toxicology and applied pharmacology.

[47]  Yuanxin Chen,et al.  Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes , 2016, Scientific Reports.

[48]  Dirk Valkenborg,et al.  Assessing the Immunosafety of Engineered Nanoparticles with a Novel in Vitro Model Based on Human Primary Monocytes. , 2016, ACS applied materials & interfaces.

[49]  C. Thaxton,et al.  Synthetic high-density lipoprotein-like nanoparticles potently inhibit cell signaling and production of inflammatory mediators induced by lipopolysaccharide binding Toll-like receptor 4. , 2016, Biomaterials.

[50]  Young Keun Kim,et al.  A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy. , 2011, Nature nanotechnology.

[51]  Manuela Semmler-Behnke,et al.  Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[52]  G. Loots,et al.  The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge , 2013, Biomaterials.

[53]  P. Choyke,et al.  Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors. , 2013, ACS nano.

[54]  K. Tachibana,et al.  A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[55]  Dan Peer,et al.  Altering the immune response with lipid-based nanoparticles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[56]  Benjamin Michen,et al.  Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages , 2014, Beilstein journal of nanotechnology.

[57]  B. Ssneha Application of Nanotechnology in Dentistry , 2014 .

[58]  Mitsuru Hashida,et al.  Ultrasound induced cancer immunotherapy. , 2014, Advanced drug delivery reviews.

[59]  Babak Mostaghaci,et al.  Transfection system of amino-functionalized calcium phosphate nanoparticles: in vitro efficacy, biodegradability, and immunogenicity study. , 2015, ACS applied materials & interfaces.

[60]  yang-xin fu,et al.  CD47 Blockade Triggers T cell-mediated Destruction of Immunogenic Tumors , 2015, Nature Medicine.

[61]  Yang Yang,et al.  Nanoparticle-based immunotherapy for cancer. , 2015, ACS nano.

[62]  M. Dobrovolskaia,et al.  Immunosuppressive and anti‐inflammatory properties of engineered nanomaterials , 2014, British journal of pharmacology.

[63]  Sung Tae Kim,et al.  Regulation of Macrophage Recognition through the Interplay of Nanoparticle Surface Functionality and Protein Corona. , 2016, ACS nano.

[64]  Byung-Soo Kim,et al.  Hyaluronate-gold nanoparticle/tocilizumab complex for the treatment of rheumatoid arthritis. , 2014, ACS nano.

[65]  J. DeSimone,et al.  Nanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[66]  P. Pelicon,et al.  Size-Dependent Effects of Gold Nanoparticles Uptake on Maturation and Antitumor Functions of Human Dendritic Cells In Vitro , 2014, PloS one.

[67]  S. Miller,et al.  Harnessing nanoparticles for immune modulation , 2015, Trends in Immunology.

[68]  Douglas M. Smith,et al.  Applications of nanotechnology for immunology , 2013, Nature Reviews Immunology.

[69]  E. M. Garzillo,et al.  Immunotoxicological impact of occupational and environmental nanoparticles exposure: The influence of physical, chemical, and combined characteristics of the particles , 2016, International journal of immunopathology and pharmacology.

[70]  D. Irvine,et al.  Synthetic Nanoparticles for Vaccines and Immunotherapy. , 2015, Chemical reviews.

[71]  J. Hahn,et al.  Cytotoxicity of, and innate immune response to, size-controlled polypyrrole nanoparticles in mammalian cells. , 2011, Biomaterials.

[72]  Morteza Mahmoudi,et al.  Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. , 2016, Nature nanotechnology.

[73]  Yvonne Perrie,et al.  Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[74]  K. Dawson,et al.  Interaction of gold nanoparticles and nickel(II) sulfate affects dendritic cell maturation , 2016, Nanotoxicology.

[75]  G. Bernardini,et al.  Engineered metal based nanoparticles and innate immunity , 2015, Clinical and Molecular Allergy.

[76]  D. Leong,et al.  Pro-inflammatory responses of RAW264.7 macrophages when treated with ultralow concentrations of silver, titanium dioxide, and zinc oxide nanoparticles. , 2015, Journal of hazardous materials.

[77]  A. Broome,et al.  Immunosuppressive nano-therapeutic micelles downregulate endothelial cell inflammation and immunogenicity. , 2015, RSC advances.

[78]  Katrin Schwarz,et al.  Nanoparticles target distinct dendritic cell populations according to their size , 2008, European journal of immunology.

[79]  M. S. Heydarnejad,et al.  Sliver nanoparticles accelerate skin wound healing in mice (Mus musculus) through suppression of innate immune system , 2014 .

[80]  Bengt Fadeel,et al.  Cytotoxic and Proinflammatory Effects of Metal-Based Nanoparticles on THP-1 Monocytes Characterized by Combined Proteomics Approaches. , 2017, Journal of proteome research.

[81]  Samir Mitragotri,et al.  Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes. , 2017, Nature nanotechnology.

[82]  Bradley Duncan,et al.  Immunomodulatory effects of coated gold nanoparticles in LPS-stimulated in vitro and in vivo murine model systems. , 2016, Chem.

[83]  H. Yoo,et al.  Multifunctional nanorods serving as nanobridges to modulate T cell-mediated immunity. , 2013, ACS nano.

[84]  Katharina Landfester,et al.  Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. , 2011, ACS nano.

[85]  C. Russell Middaugh,et al.  Nanotechnology in vaccine delivery☆ , 2008, Advanced Drug Delivery Reviews.

[86]  Alke Petri-Fink,et al.  Aerosol Delivery of Functionalized Gold Nanoparticles Target and Activate Dendritic Cells in a 3D Lung Cellular Model. , 2017, ACS nano.

[87]  T. Fahmy,et al.  Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacy. , 2016, Biomaterials.

[88]  Bo Yan,et al.  Fabrication of Corona-Free Nanoparticles with Tunable Hydrophobicity , 2014, ACS nano.

[89]  C. Dong,et al.  Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting and Drug Delivery. , 2017, Small.

[90]  Yan Wang,et al.  Stealth Immune Properties of Graphene Oxide Enabled by Surface-Bound Complement Factor H. , 2016, ACS nano.

[91]  Katharina Landfester,et al.  Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. , 2016, Nature nanotechnology.

[92]  E. Conway,et al.  Modulation of complement activation and amplification on nanoparticle surfaces by glycopolymer conformation and chemistry. , 2014, ACS nano.

[93]  W. Urba,et al.  The Effect of Superparamagnetic Iron Oxide Nanoparticle Surface Charge on Antigen Cross-Presentation , 2017, Nanoscale Research Letters.

[94]  M. Bachmann,et al.  Harnessing Nanoparticles for Immunomodulation and Vaccines , 2017, Vaccines.

[95]  Samir Mitragotri,et al.  Macrophages Recognize Size and Shape of Their Targets , 2010, PloS one.

[96]  T. Kawabata,et al.  Development of Immunotoxicity Testing Strategies for Immunomodulatory Drugs , 2012, Toxicologic pathology.

[97]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[98]  S. Standley,et al.  Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles , 2005, Journal of Controlled Release.

[99]  Wen Jiang,et al.  Designing nanomedicine for immuno-oncology , 2017, Nature Biomedical Engineering.

[100]  Konstantin Sokolov,et al.  Preventing protein adsorption and macrophage uptake of gold nanoparticles via a hydrophobic shield. , 2012, ACS nano.

[101]  Diana Boraschi,et al.  Endotoxin Contamination in Nanomaterials Leads to the Misinterpretation of Immunosafety Results , 2017, Front. Immunol..

[102]  M. Lotze,et al.  PAMPs and DAMPs: signal 0s that spur autophagy and immunity , 2012, Immunological reviews.

[103]  S. Magdassi,et al.  Conductive nanomaterials for printed electronics. , 2014, Small.

[104]  Martin Bencsik,et al.  Artificial exosomes as tools for basic and clinical immunology. , 2009, Journal of immunological methods.

[105]  V. Rotello,et al.  Modulation of Immune Response Using Engineered Nanoparticle Surfaces. , 2016, Small.

[106]  Louis W. Chang,et al.  Metal-Based Nanoparticles and the Immune System: Activation, Inflammation, and Potential Applications , 2015, BioMed research international.

[107]  Hideyoshi Harashima,et al.  A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[108]  D. Shepherd,et al.  Environmental Immunology: Lessons Learned from Exposure to a Select Panel of Immunotoxicants , 2016, The Journal of Immunology.

[109]  Yusuke Suzuki,et al.  A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases , 2014, PloS one.